Research and development is the basis of discovery, invention and innovation and are the pillars of modern science and medicine. At Alkem Lab's, we understand the importance of research and development and its impact on the credibility of the product, business goodwill and well being of society.

Alkem Lab's has stressed focus on R&D with its proficient teams of scientists and pharmacists backed by state-of-the-art infrastructure and technology in all areas of generic research as a short to medium term strategy. Generic drug development encompasses both, small and large molecules.

We recognize the business potential in the opportunities in the highly competitive global markets not just for vanilla generics, but also in value added and difficult to develop complex generics. Our business goals are backed by our advanced manufacturing facilities that enable compliance with regulatory standards in advanced markets. Our focus on the generics business strategy will provide us a sustainable model to move up the value chain. Alkem Lab's R&D prides on its team of over 300 scientists with inherent strength in analytical chemistry and exceptional credentials in all fields of drug development to propel the organization and reach its objectives.

Our generic drug development is at par with international quality standards and schedules thanks to our in-house R&D centre situated at Taloja, Navi Mumbai.

Alkem Lab's proudly claims its own bioavailability and bioequivalence testing facilities that fulfill the standards set by international regulatory agencies including US - FDA, UK – MHRA & TGA – Australia.

Backward integration through in-house API development and front-end efficient marketing and distribution of products provides the desired impetus to the generics program from development to commercialization.